EQS-Adhoc
LifeWatch AG: LifeWatch accepts offer from back-stop investor for ordinary capital increase
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM
LifeWatch AG: LifeWatch accepts offer from back-stop investor for ordinary
capital increase
14.04.2016 / 22:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.
LifeWatch AG: LifeWatch accepts offer from back-stop investor for ordinary
capital increase
14.04.2016 / 22:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
LifeWatch accepts offer from back-stop investor for ordinary capital
increase
Zug/Switzerland, April 14, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE),
a leading developer and provider of medical solutions and remote diagnostic
monitoring services to the digital health market announces that a back-stop
investor, Aevis Victoria SA, has provided a guarantee to purchase any
shares remaining unsubscribed in the ordinary capital increase being
proposed to the shareholders at the Annual General Meeting of April 15,
2016. The proposed ordinary capital increase will involve subscription
rights being granted to all shareholders.
The offer also includes changes to the proposed candidates under the agenda
item "Elections" at the Annual General Meeting including the expansion of
the Board of Directors to six members. These changes are detailed below:
The previously proposed candidates, Dr. Didier Hoch and John Doulis, have
withdrawn their candidature and the Board of Directors now recommends
Antoine Kohler, Antoine Hubert and Robert Bider as Board Candidates, in
addition to the previously proposed Patrick Schildknecht, Thomas Ruehle and
Raymond W. Cohen. The Board of Directors also proposes that Robert Bider be
elected as Chairman of the Board. Furthermore, in addition to Thomas
Ruehle, the Board of Directors recommends Antoine Hubert and Raymond W.
Cohen as members of the Compensation Committee replacing John Doulis and
Dr. Didier Hoch.
For further questions:
LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35 / +41 79 410 81 88
E-mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solutions' company,
specializing in advanced digital health systems and wireless remote
diagnostic patient monitoring services. LifeWatch's services provide
physicians with critical information to determine appropriate treatment and
thereby improve patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the parent
LifeWatch accepts offer from back-stop investor for ordinary capital
increase
Zug/Switzerland, April 14, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE),
a leading developer and provider of medical solutions and remote diagnostic
monitoring services to the digital health market announces that a back-stop
investor, Aevis Victoria SA, has provided a guarantee to purchase any
shares remaining unsubscribed in the ordinary capital increase being
proposed to the shareholders at the Annual General Meeting of April 15,
2016. The proposed ordinary capital increase will involve subscription
rights being granted to all shareholders.
The offer also includes changes to the proposed candidates under the agenda
item "Elections" at the Annual General Meeting including the expansion of
the Board of Directors to six members. These changes are detailed below:
The previously proposed candidates, Dr. Didier Hoch and John Doulis, have
withdrawn their candidature and the Board of Directors now recommends
Antoine Kohler, Antoine Hubert and Robert Bider as Board Candidates, in
addition to the previously proposed Patrick Schildknecht, Thomas Ruehle and
Raymond W. Cohen. The Board of Directors also proposes that Robert Bider be
elected as Chairman of the Board. Furthermore, in addition to Thomas
Ruehle, the Board of Directors recommends Antoine Hubert and Raymond W.
Cohen as members of the Compensation Committee replacing John Doulis and
Dr. Didier Hoch.
For further questions:
LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35 / +41 79 410 81 88
E-mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solutions' company,
specializing in advanced digital health systems and wireless remote
diagnostic patient monitoring services. LifeWatch's services provide
physicians with critical information to determine appropriate treatment and
thereby improve patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the parent
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte